+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharma Regulatory Management Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Pharma Regulatory Management Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Pharma Regulatory Management Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • March 2025
  • Region: Global
  • TechSci Research
  • ID: 5908204
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Global Pharma Regulatory Management Systems Market was valued at USD 9.98 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.95% through 2030. The Global Pharma Regulatory Management Systems Market refers to the industry that encompasses the development and adoption of specialized software solutions and technologies designed to facilitate regulatory compliance and streamline regulatory processes within the pharmaceutical and life sciences sector. This is ascribed due to rising cancer cases, growing cardiovascular diseases, aging popultion, etc.

For instance, according to GLOBOCAN 2022 data, global cancer incidence surpassed 19.9 million cases. The highest number of cases was reported in Asia, with over 9.8 million, followed by Europe with 4.4 million and North America with 2.6 million. This data highlights regional disparities in cancer prevalence, emphasizing the growing healthcare burden worldwide. Therefore, in order to manage these issues, the regulatory committee of pharmaceutical is growing rapidly.

Key Market Drivers

Rising Regulatory Complexity

The pharmaceutical industry operates in a highly regulated environment, where adherence to stringent regulatory standards is paramount to ensure the safety, efficacy, and quality of pharmaceutical products. Over the years, the regulatory landscape governing this industry has become increasingly complex, with a growing number of guidelines, requirements, and compliance standards imposed by regulatory authorities worldwide. This rising regulatory complexity has emerged as a significant driving force behind the rapid growth of the Global Pharma Regulatory Management Systems (PRMS) Market.

For instance, Japan’s Central Social Insurance Medical Council approved a drug repricing system expected to lead to an average price reduction of approximately 4.38%. This system covers nearly 17 top-selling drugs, including Vyndaqel, Samsca, Revlimid, Lynparza, Stelara, and Dupixent. In April 2023, the prices of over 2,000 drugs in Japan saw an average reduction of 9.4%. These developments are likely to impact pharmaceutical regulatory managemnet systems market in the near future.

Key Market Challenges

Rapidly Evolving Regulations

One of the foremost challenges is the ever-changing regulatory landscape in the pharmaceutical industry. Regulatory bodies like the U.S. FDA and the EMA continually update and revise guidelines, making it challenging for PRMS providers to keep their systems aligned with the latest requirements. Pharmaceutical companies require agile solutions that can adapt to evolving standards.

Key Market Trends

Cloud-Based Solutions for Flexibility

Cloud computing is becoming increasingly prevalent in the pharmaceutical industry. Cloud-based PRMS solutions offer scalability, flexibility, and the ability to access data and tools from anywhere. This trend will enable smaller pharmaceutical companies to adopt PRMS without significant upfront infrastructure costs.

Key Market Players

  • Instem PLC
  • NNIT A/S
  • EXTEDO
  • Amplexor USA Inc
  • MasterControl Inc
  • Charles River Laboratories International Inc.
  • Parexel International Corporation
  • IQVIA Inc.
  • ICON Inc.
  • Pharmalex GmbH

Report Scope:

In this report, the Global Pharma Regulatory Management Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharma Regulatory Management Systems Market, By Component:

  • Services
  • Solutions

Pharma Regulatory Management Systems Market, By Deployment:

  • On-Cloud
  • On-Premises

Pharma Regulatory Management Systems Market, By End User:

  • Government Agencies
  • Hospitals & Care Providers
  • Pharmaceutical & Biotechnology Companies

Pharma Regulatory Management Systems Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharma Regulatory Management Systems Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pharma Regulatory Management Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Services, Solutions)
5.2.2. By Deployment (On-Cloud, On-Premises)
5.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Component
5.3.2. By Deployment
5.3.3. By End User
5.3.4. By Region
6. North America Pharma Regulatory Management Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component (Services, Solutions)
6.2.2. By Deployment (On-Cloud, On-Premises)
6.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharma Regulatory Management Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Deployment
6.3.1.2.3. By End User
6.3.2. Canada Pharma Regulatory Management Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Deployment
6.3.2.2.3. By End User
6.3.3. Mexico Pharma Regulatory Management Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Deployment
6.3.3.2.3. By End User
7. Europe Pharma Regulatory Management Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component (Services, Solutions)
7.2.2. By Deployment (On-Cloud, On-Premises)
7.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pharma Regulatory Management Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Deployment
7.3.1.2.3. By End User
7.3.2. United Kingdom Pharma Regulatory Management Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Deployment
7.3.2.2.3. By End User
7.3.3. France Pharma Regulatory Management Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Deployment
7.3.3.2.3. By End User
7.3.4. Italy Pharma Regulatory Management Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Deployment
7.3.4.2.3. By End User
7.3.5. Spain Pharma Regulatory Management Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Deployment
7.3.5.2.3. By End User
8. Asia-Pacific Pharma Regulatory Management Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component (Services, Solutions)
8.2.2. By Deployment (On-Cloud, On-Premises)
8.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharma Regulatory Management Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Deployment
8.3.1.2.3. By End User
8.3.2. Japan Pharma Regulatory Management Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Deployment
8.3.2.2.3. By End User
8.3.3. India Pharma Regulatory Management Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Deployment
8.3.3.2.3. By End User
8.3.4. Australia Pharma Regulatory Management Systems Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Deployment
8.3.4.2.3. By End User
8.3.5. South Korea Pharma Regulatory Management Systems Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Deployment
8.3.5.2.3. By End User
9. South America Pharma Regulatory Management Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component (Services, Solutions)
9.2.2. By Deployment (On-Cloud, On-Premises)
9.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharma Regulatory Management Systems Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Deployment
9.3.1.2.3. By End User
9.3.2. Argentina Pharma Regulatory Management Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Deployment
9.3.2.2.3. By End User
9.3.3. Colombia Pharma Regulatory Management Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Deployment
9.3.3.2.3. By End User
10. Middle East and Africa Pharma Regulatory Management Systems Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component (Services, Solutions)
10.2.2. By Deployment (On-Cloud, On-Premises)
10.2.3. By End User (Government Agencies, Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharma Regulatory Management Systems Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Deployment
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Pharma Regulatory Management Systems Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Deployment
10.3.2.2.3. By End User
10.3.3. UAE Pharma Regulatory Management Systems Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Deployment
10.3.3.2.3. By End User
10.3.4. Kuwait Pharma Regulatory Management Systems Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Component
10.3.4.2.2. By Deployment
10.3.4.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Instem PLC
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. NNIT A/S
14.3. EXTEDO
14.4. Amplexor USA Inc
14.5. MasterControl Inc
14.6. Charles River Laboratories International Inc.
14.7. Parexel International Corporation
14.8. IQVIA Inc.
14.9. ICON Inc.
14.10. Pharmalex GmbH
15. Strategic Recommendations16 About the Publisher & Disclaimer

Companies Mentioned

  • Instem PLC
  • NNIT A/S
  • EXTEDO
  • Amplexor USA Inc
  • MasterControl Inc
  • Charles River Laboratories International Inc.
  • Parexel International Corporation
  • IQVIA Inc.
  • ICON Inc.
  • Pharmalex GmbH

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.49 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharma Regulatory Management Systems Market by Component, Deployment, End User - Global Forecast 2025-2030 - Product Image

Pharma Regulatory Management Systems Market by Component, Deployment, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Pharma Knowledge Management Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Pharma Knowledge Management Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Pharma 4.0 Market Report 2025 - Product Image

Pharma 4.0 Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pharmaceutical Supply Chain Management Market Report 2025 - Product Image

Pharmaceutical Supply Chain Management Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pharma 4.0 - Global Strategic Business Report - Product Image

Pharma 4.0 - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.